DECR1 and heart failure: Given the role of Decr1 in fatty acid metabolism, future studies could explore the potential benefits of Decr1 inhibitors in other cardiometabolic diseases, such as obesity‐related cardiomyopathy or heart failure with preserved ejection fraction (HFpEF).